NAL 0.00% 0.6¢ norwood abbey limited

human trials, page-15

  1. 483 Posts.
    This product is the tip of the iceberg with endless applications in other medical and technological developments...

    I think more grants of Patents will flow from this for other applications



    In time need for current style syringe needles will be a thing of the past....current needle sales worldwide would be currentlyworth billions of dollars alone....
 
watchlist Created with Sketch. Add NAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.